RT Journal Article
SR Electronic
T1 Core outcome set for clinical trials of stent implantation in coronary heart disease -- a systematic review and mixed-method consensus study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.09.24310182
DO 10.1101/2024.07.09.24310182
A1 Wan, Xingli
A1 Wang, Xinyi
A1 Li, Xia
A1 Long, Youlin
A1 Li, Zhengchi
A1 Du, Liang
YR 2024
UL http://medrxiv.org/content/early/2024/07/16/2024.07.09.24310182.abstract
AB Background Although various types of stent interventions have been found in clinical trials to be effective in treating coronary heart disease, researchers often use heterogeneous outcome measures. This can preclude the comparison of results across studies and prevent effective meta-analyses from answering important clinical questions. The need to standardize outcome measure reporting is urgent. This study aims to produce a core outcome set(COS) for coronary stent implantation research.Methods We performed a systematic review via the PubMed and EMBASE databases and then synthesized recommendations from international standardized endpoint definitions and consensus documents to generate a list of potential outcomes. We conducted a two-round Delphi survey, achieving the iterative selection of potential outcomes. A multidisciplinary panel of experts and patients with coronary stent implantation experience rated the importance of candidate outcomes on a 9-point Likert scale. To be provisionally accepted, outcomes needed to be critical important (score 7-9, with 9 being the maximum) by 70% of each stakeholder group. Finally, we held a consensus meeting to discuss and generate the COS.Results A total of seventy-two potential outcomes were identified by systematic literature review. We obtained nine key consensus documents to inform the standardized definitions of the outcomes. After duplication and combination of similar outcomes, 26 of the 72 outcomes assigned into five outcome domains were included in the Delphi surveys. Twenty outcomes were provisionally accepted. Following the consensus meetings, the agreement was reached on a twelve-item COS.Conclusion We developed a COS for coronary stent implantation in coronary heart disease. Its implementation will facilitate the standardization reporting of clinical trials and reduce the heterogeneity in assessment in future research. Further research may help determine the specific, validated measurement instruments to assess each outcome.What is KnownCoronary stent implantation is consider to be the primary method for treating coronary heart disease.Many trials use heterogeneous effectiveness and safety outcome measures with different defined and non-patient concerned outcome measures, which would largely prevent meta-analyses and contribute to selective reporting bias.What the Study AddsWe initially develop the first core outcome set(COS) of coronary stent implantation intervention for China to facilitate the standardization reporting of clinical trials and enable meta-analysis.In our study, patient concerned outcome measure were thoroughly discussed and included in the COS by extensively involved patient representatives in every step of the project.Although we used rigorous method to development the COS, it should be updated as new evidence emerges in this rapidly evolving field.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study aimed to develop a core outcome set for coronary heart disease based on the consensus method,not a clinical trial. As to our knowledge, studies to develop core outcome sets are not required to mandatory registrationFunding StatementTwo projects funded by the National Natural Science Foundation of China (No.81873197 and 72074161) supported the research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This review does not involve any human or animal experiments and therefore does not require ethical approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAdditional data can be obtained from the supplementary materials. The deidentified participant data will not be shared.